Search Results 331-340 of 16965 for pharmacogenetics
The primary objective of this open-label, LTFU study is to evaluate the long-term safety and tolerability of sotatercept when added to background PAH therapy in ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
This study will determine the validity of predictive and surrogate biomarkers for the detection of Parkinson's disease and Parkinson's disease cognitive decline ...
View research faculty in the Department of Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic.
Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “O” to learn about drug side effects, proper use and ...
The Genome Analysis Core at Mayo Clinic offers DNA and RNA next-generation sequencing (NGS), gene expression and genotyping services for researchers.
The purpose of this study is to to bring molecular risk prediction for breast cancer into the clinical arena through: the establishment of a large tissue ...
COVID-19 · Dana Sparks. December 22, 2020 ; Arizona · Jay Furst. December 22, 2020 ; Cancer · Jennifer O'Hara. December 19, 2020 ; Individualized Medicine · Colette ...
Antiemetic drugs, such as palonosetron hydrochloride, ondansetron, and granisetron hydrochloride, may help lessen or prevent nausea and vomiting in patients ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.